Lifco AB has acquired a majority stake in Rhein83 Srl

Juli 2018 — Lifco AB has acquired a majority stake in the Italian dental company Rhein83 Srl. Financial details have not been disclosed.

Lifco acquires and develops market-leading niche operations with the potential to deliver sustainable profit growth and strong cash flows. The group is listed on Nasdaq Stockholm and has three business areas: dental, demolition & tools and systems solutions. The company has a clear corporate philosophy which implies a long-term perspective, focus on profits and a highly decentralized organization. As of today, the investment group controls circa140 companies in 30 countries, generating revenues of over US$1 billion.

Established in 1983 and located in Bologna, Italy, Rhein83 has innovated the dental market with the introduction of elastic spherical attachments (previously were only metallic) for dental implants. The company's technology is highly recognized and appreciated worldwide.

Vår roll i transaktionen

Oaklins' team in Italy advised the buyer in this transaction.

Uppdrag

Företagsförvärv

Parter

“Italy has many leading companies active in niche markets. Rhein83 is one of them. We are very excited for having complete this first acquisition in Italy and we hope this will be the first of many other acquisitions, both in the dental and industrial sectors, where we are discovering outstanding companies with great performance.”

Ingvar Ljungqvist

Head of Acquisitions, Lifco AB

Prata med transaktionsteamet

Giuseppe Maria Bernardo Puccio

Principal

Milano, Italien
Oaklins Italy

Se profil Kontakta oss

Relaterade transaktioner

UKAT Group has acquired Bayberry Limited

Riskkapital | Hälsovård

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Lär dig mer

Medicija has acquired Saulės Šeimos Medicinos Centras

Hälsovård

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Lär dig mer

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Hälsovård

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Lär dig mer